Issue link: https://viewer.e-digitaledition.com/i/1421339
Dr. Christopher Wang is this area's sports medicine specialist who has worked with the Pittsburgh Pirates and USA Rugby as well as the Pittsburgh Riverhounds a USL (United Soccer League) national soccer club, and has extensive experience working with high school athletes. In addition he has worked in a Level 1 Trauma facility for Orthopedic Surgery and completed a fellowship in Orthopedic Sports Medicine. Not only that but he has been active in athletics including earning a Black Belt in Martial Arts. So whether you're headed for the pros or just want to heal like one, call Dr. Christopher Wang – Don't play games with your sports injury. Dr. Christopher Wang, DO Auburn Orthopaedic Specialists PREVIOUS CLIENTS OF DR. WANG DR. WANG IS ACCEPTING NEW PATIENTS. PLEASE CONTACT: 315-252-7559 Auburn Orthopaedic Specialists | 77 Nelson Street Suite 130 & Suite 210 | Auburn, NY WE WILL GET YOU BACK IN THE GAME. Bundled Payments for Bariatric Surgery May Cut Costs E N C O U R A G I N G E M P L OY E E S T O use specific providers with agreed-to set costs for bariatric surgery saves employees and employers money, according to a study by the RAND Corporation. "Bundled payments are gaining popularity in the Medicare system, but have not been adopted as widely by private insurance plans," wrote Christopher M. Whaley, the study's lead author and a policy researcher at RAND. Using a program that waives patient copays, negotiates pricing and bundles all care — like surgery, hospital stays and aftercare for 30 days — together, total costs were reduced by over 10% and patient payments decreased nearly 28%. The study looked at total knee and hip replacement, spinal fusion, and bariatric weight loss procedures. It also found employers saved around $7 for every $1 waived in patient copays. n — Cari Wade Gervin Two New Weight Loss Treatments Show Promise O V E R T H E S U M M E R , the FDA approved Wegovy injections for chronic weight management, the first such drug approved since 2014. Manufactured by Novo Nordisk, the drug works by mimicking the hormone glucagon-like peptide-1 (GLP-1), which helps regulate appetite. It was studied in four 68-week trials. Meanwhile, the 2019-FDA-cleared Plenity, a non-medication ingestible weight loss device, is set to expand sales nationwide by the end of 2021. Currently available only by online prescription via its website, manufacturer Gelesis expects to reach 100% capacity by December 2021, with more expansion expected in 2022. Plenity already has 48,000 users and a partnership with WW (formerly known as Weight Watchers). The capsules taken before meals help users feel full and eat less, according to a randomized, double- blind, placebo-controlled study. n — Cari Wade Gervin T H A T ' S N E W S